Position in PSNL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$660,030
-$2,209,110 QoQ
Shares Held
49,256
-88.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#81
of 157 holders
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $101,462,417 across 18 Diagnostics & Research names. PSNL ranks #14 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
164,518 | $24,682,635 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
32,661 | $16,374,918 | |
| 3 | QGEN |
Qiagen N.V.
|
321,161 | $12,557,395 | |
| 4 | A |
Agilent Technologies, Inc.
|
68,639 | $9,117,318 | |
| 5 | DHR |
Danaher Corp /De/
|
45,615 | $8,688,745 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
12,971 | $6,828,453 | |
| 7 | CDNA |
CareDx, Inc.
|
214,342 | $6,108,747 | |
| 8 | VCYT |
Veracyte, Inc.
|
94,044 | $5,523,204 |
All Filings in PSNL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $660,030 | 49,256 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $2,869,140 | 437,369 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $119,943 | 34,172 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $133,252 | 23,054 | Shares | Sole | 2025-02-12 | |
| 2020-12-31 | $3,563,617 | 97,340 | Shares | Other | 2021-02-16 | |
| 2020-06-30 | $267,182 | 20,600 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||